1. Long-Term Follow-Up of Stem Cell Therapy after Acute Myocardial Infarction
- Author
-
Hans F. Dohmann, Rodrigo C Moreira, Andre L.S. Souza, Radovan Borojevic, Karla Menezes, Fábio Antônio Abrantes Tuche, Sabrina Bernardez Pereira, Suzana Alves, Andrea Ferreira Haddad, and Rose Frajtag
- Subjects
medicine.medical_specialty ,medicine.drug_class ,business.industry ,Long term follow up ,medicine.medical_treatment ,Stem-cell therapy ,medicine.disease ,Internal medicine ,medicine ,Cardiology ,Etiology ,Myocardial infarction ,Cardiology and Cardiovascular Medicine ,business ,Beta blocker ,Rest (music) - Abstract
Age 76 (65-83) 76 (64-84) 76 (67-82) 0.382 Gender (% Female) 51.6 52.4 49.3 !0.01 Race (% Caocasion) 76.4 74.3 82.0 !0.01 Ishcemic etiology 45.7 45.0 47.7 !0.01 Atrial arrhythomia 30.8 30.0 32.9 !0.01 Pulmonary HTN 6.3 5.3 8.7 !0.01 Renal insufficiency 19.6 19.3 20.4 !0.01 Dyspnea at rest 43.8 42.5 47.1 !0.01 BNP 804 (407-1670) 835 (425-1720) 735 (360-1540) !0.01 Troportin (Abnormal) 21.0 21.4 20.1 !0.01 Discharge beta blocker 67.9 70.2 62.7 !0.01 Discharge ACE-imbioitor 56.0 57.6 52.3 !0.01
- Published
- 2011
- Full Text
- View/download PDF